A. Kastanayan

CARDIO-VASCULAR СALCIFICATION RISK PROGNOSIS IN PATIENTS RECEIVING CHRONIC HEMODIALYSIS

M. Batiushin, И. Руденко, М. М. Батюшин, 2015 .

[Treatment of Patients with Stable Manifestations of Atherosclerotic Vascular Disease: New Possibilities (Conclusion of the Council of Experts from November 16, 2018, Rostov-on-Don)].

D. V. Frolov, R. Sidorov, L. Khaisheva, 2019, Kardiologiia.

Relationship of markers of muscle metabolism with the features of diet in patients on hemodialysis

M. Batiushin, A. Kastanayan, A. Kuzyarova, 2020, South Russian Journal of Therapeutic Practice.

Complex Assessment of Risk Factors for the Development of Cardiovascular Calcification in Hemodialysis Patients

E. Kartashova, M. Batiushin, D. G. Pasechnik, 2016 .

OP0232 NETAKIMAB REDUCES THE DISEASE ACTIVITY OF RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS. RESULTS OF ASTERA STUDY

V. Mazurov, I. Gordeev, T. Dubinina, 2019, Oral Presentations.

Efficacy and safety of netakimab, anti-IL-17A monoclonal antibody, in patients with ankylosing spondylitis. Results of phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA

V. Mazurov, S. Lapshina, I. Gordeev, 2020, Rheumatology Science and Practice.

Long-Term Outcomes of Pharmacoinvasive Reperfusion Strategy Depending on the Choice of Thrombolytic Agent in ST-Segment Elevation Myocardial Infarction

A. Khripun, Y. Kulikovskikh, A. Kastanayan, 2019, Rational Pharmacotherapy in Cardiology.

Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR

V. Mazurov, A. Lila, M. Korolev, 2023, Rheumatology Science and Practice.

Long-term efficacy and safety of netakimab in the treatment of ankylosing spondylitis: results of Phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA

S. Lapshina, I. Gordeev, T. Dubinina, 2020, Modern Rheumatology Journal.